Target- |
MechanismCell replacements |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Safety and Efficacy Investigation of Patients With Parkinson's Disease by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells
This study is to evaluate the safety and efficacy of Umbilical Cord Derived Mesenchymal Stem Cells transplantation in Parkinson's disease.
100 Clinical Results associated with Hebei Newtherapy BIo-Pharma technology Co., Ltd.
0 Patents (Medical) associated with Hebei Newtherapy BIo-Pharma technology Co., Ltd.
100 Deals associated with Hebei Newtherapy BIo-Pharma technology Co., Ltd.
100 Translational Medicine associated with Hebei Newtherapy BIo-Pharma technology Co., Ltd.